Bio-Rad Laboratories BIO
NYSE BIO
$377.48 +13.21 (+3.63%)
At close: Aug 20, 2026 · 2:22 PM UTC

Bio-Rad Laboratories (BIO) Gross Margin Growth (5y) (2014 - 2026)

Bio-Rad Laboratories (BIO) Gross Margin Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.44 Bn 193.84 Bn 7.27 Bn
2 Stryker 127.32 Bn 123.85 Bn 4.50 Bn
3 Medtronic 118.87 Bn 109.65 Bn 6.41 Bn
4 Boston Scientific 73.47 Bn 72.93 Bn 3.85 Bn
5 Edwards Lifesciences 51.90 Bn 47.65 Bn 1.35 Bn
6 Dexcom 34.30 Bn 32.36 Bn 830.00 Mn
7 GE HealthCare Technologies 33.74 Bn 31.63 Bn 2.18 Bn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn
9 Steris 23.05 Bn 22.56 Bn 684.20 Mn
10 Bio-Rad Laboratories 10.10 Bn 8.48 Bn 345.80 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -291.00
Mar 31, 2026 -285.00
Dec 31, 2025 -846.00
Sep 30, 2025 -416.00
Jun 30, 2025 -158.00
Mar 31, 2025 -326.00
Dec 31, 2024 -167.00
Sep 30, 2024 2.00
Jun 30, 2024 186.00
Mar 31, 2024 -293.00
Dec 31, 2023 -14.00
Sep 30, 2023 51.00
Jun 30, 2023 84.00
Mar 31, 2023 -125.00
Dec 31, 2022 -119.00
Sep 30, 2022 -125.00
Jun 30, 2022 298.00
Mar 31, 2022 350.00
Dec 31, 2021 -44.00
Sep 30, 2021 349.00